Franklin M. Berger, Director at Atea Pharmaceuticals, Inc. (AVIR), sold 57,832 shares at $5.15 ($298K) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $298k AVIR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.15 | 25,500 | $131K | 44.0% |
| 2 | $5.16 | 16,166 | $83K | 28.0% |
| 3 | $5.16 | 16,166 | $83K | 28.0% |
| Total | $5.16 avg | 57,832 | $298K | 100% |
| Filing → |
| EPIX | BUY | 2023-11-22 | $267K | — | Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |